More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.23B
EPS
3.95
P/E ratio
11.1
Price to sales
1.18
Dividend yield
--
Beta
1.671474
Previous close
$33.31
Today's open
$33.06
Day's range
$32.90 - $34.25
52 week range
$17.11 - $51.86
show more
CEO
Larry Lei Wu
Employees
1561
Headquarters
El Monte, CA
Exchange
NASDAQ Global Market
Shares outstanding
36787488
Issue type
Common Stock
Technology
Software & IT Services
GCT Semiconductor Announces Strategic Commitment to Powering the AI-Edge Data Pipeline
SAN JOSE, Calif.--(BUSINESS WIRE)-- #4G--GCT SEMICONDUCTOR ANNOUNCES STRATEGIC COMMITMENT TO POWERING THE AI-EDGE DATA PIPELINE.
Business Wire • Jun 23, 2026

GigaCloud Technology Inc. (GCT) Dips More Than Broader Market: What You Should Know
In the latest trading session, GigaCloud Technology Inc. (GCT) closed at $33.32, marking a -1.94% move from the previous day.
Zacks Investment Research • Jun 22, 2026

Is Trending Stock GigaCloud Technology Inc. (GCT) a Buy Now?
GigaCloud Technology Inc. (GCT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks Investment Research • Jun 19, 2026

GigaCloud Technology Inc. (GCT) Outperforms Broader Market: What You Need to Know
The latest trading day saw GigaCloud Technology Inc. (GCT) settling at $34.1, representing a +1.94% change from its previous close.
Zacks Investment Research • Jun 12, 2026

GigaCloud Soars 70+% In One Year Despite U.S. Furniture Sale Declines
GigaCloud Technology is recognized as a 'World Growth Leader of 2026' and delivers robust growth despite headwinds in the U.S. furniture market. GCT posted Q1 2026 revenue of $359.49M (+32% YoY), gross profit up 35%, and net income up 41%, significantly beating EPS expectations. The company's diversified global network and Supplier Fulfilled Retailing® model enable resilience and expansion beyond U.S. market weakness.
Seeking Alpha • Jun 11, 2026

GigaCloud Technology Inc to Present at Sidoti Small Cap Conference
EL MONTE, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that Erica Wei, its Chief Financial Officer, and Iman Schrock, its President, will present at the virtual Sidoti Small Cap Conference on Wednesday, June 17, 2026, at 11:30 a.m. ET/8:30 a.m. ET.
GlobeNewsWire • Jun 10, 2026

GigaCloud Technology: Cheap, Profitable, And Still Underestimated
I reiterate GigaCloud Technology as a Buy with a $56 price target, implying 76% upside from the current price of $31. My main growth drivers are Europe, the 3P/SFR marketplace mix, New Classic integration, category expansion, and buybacks. In my model, I estimate these drivers can push 2027 revenue toward $1.89Bn and EPS toward $5.05.
Seeking Alpha • Jun 10, 2026

Is Most-Watched Stock GigaCloud Technology Inc. (GCT) Worth Betting on Now?
Recently, Zacks.com users have been paying close attention to GigaCloud Technology Inc. (GCT). This makes it worthwhile to examine what the stock has in store.
Zacks Investment Research • Jun 8, 2026

GigaCloud Technology Inc Named to TIME's ‘World's Growth Leaders 2026' List
EL MONTE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced its inclusion in TIME's World's Growth Leaders 2026 list, a global ranking of publicly listed companies demonstrating sustained revenue growth, financial strength, and long-term market performance.
GlobeNewsWire • Jun 3, 2026

Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program
SAN DIEGO, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Sapu Nano and Oncotelic Therapeutics (OTCQB:OTLC) today announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global Clinical Trials (GCT) as the lead contract research organization supporting international execution of Study SP-03-B101.
GlobeNewsWire • Jun 3, 2026

¹ Disclosures

Open an M1 investment account to buy and sell GigaCloud Technology Inc commission-free¹. Build wealth for the long term using automated trading and transfers.